Dr. Shapira is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
180 White Rd
Little Silver, NJ 07739Phone+1 732-530-8666Fax+1 732-530-4139
Summary
- I am a board certified oncologist, hematologist and internal medicine doctor. I have over a decade experience in Oncology Leadership both in Integrated private and academic oncology settings.
Education & Training
- SUNY Downstate Health Sciences UniversityFellowship, Hematology and Medical Oncology, 2002 - 2005
- Rutgers Health/Cooperman Barnabas Medical CenterResidency, Internal Medicine, 1995 - 1998
- Carol Davila University of Medicine and PharmacyClass of 1990
Certifications & Licensure
- NY State Medical License 2002 - 2026
- CT State Medical License 2019 - 2025
- MD State Medical License 2019 - 2025
- NJ State Medical License 2019 - 2025
- WY State Medical License 2019 - 2025
- PA State Medical License 2019 - 2024
- AR State Medical License 1997 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Awards, Honors, & Recognition
- Top Oncologist Castle Connolly, 2020
Clinical Trials
- A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Start of enrollment: 2010 Aug 13
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Publications & Presentations
PubMed
- Treatment of Acute Myeloid Leukemia in the Community Setting.Taha Al-Juhaishi, Servillano Dela Cruz, Rohan Gupta, Gina Keiffer, Vicki A Morrison
The Oncologist. 2024-09-06 - 51 citationsAdjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial.Sara M Tolaney, Paolo Tarantino, Noah Graham, Nabihah Tayob, Laia Parè
The Lancet. Oncology. 2023-03-01 - 6 citationsPrivacy Concerns About Personal Health Information and Fear of Unintended Use of Biospecimens Impact Donations by African American PatientsArthi Reddy, Abhimanyu Amarnani, Michael Chen, Sophia Dynes, Bryan Flores
Journal of Cancer Education. 2020-06-01
Press Mentions
- Dr Iuliana Shapira Weighs in on How Data Analytics Can Improve Revenue CycleAugust 8th, 2019
- Hopeful News for Cancer Patients from Iuliana Shapira, MD, RCCA's Chief Medical OfficerJuly 25th, 2019
- ® Announces the Institute for Value-Based Medicine® VB-Onc™ Meeting in New JerseyJune 6th, 2019
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: